VSQ – Q2 2021 April 2, 2021 VSQ / VSQ+ The Q2 2021 issue of the Vaccine Safety Quarterly (VSQ) newsletter is now available here! Continue Reading Previous PostBC ISPE Vax SIG Journal Club January 2021: “Safety & Immunogenicity of a Vector-Based Heterologous Prime-Boost COVID-19 Vaccine in Two Formulations”Next PostBC ISPE Vax SIG Journal Club April 2021: “BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting”
